|Articles|May 1, 2018
- Pharmaceutical Executive-05-01-2018
- Volume 38
- Issue 5
Pharmaceutical Executive, May 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Brands of the Year: Promise and Challengeover 7 years ago
Gauging the Collaborative Spirit in European Healthover 7 years ago
Gottlieb Tackles Drug Competition & Costsover 7 years ago
Deploying the Cloud in GxP Environmentsover 7 years ago
So Much Depends on the Physicianover 7 years ago
Bridging Science & Strategy: An Investor’s Eyeover 7 years ago
Patient Empowerment and the Future of Pharma Advertisingover 7 years ago
Closing Pharma’s Digital Divideover 7 years ago
Patient KOLs: Their Guide to Entering Crowded Marketsover 7 years ago
The Total Care PackageNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
